Histamine H3 receptors depress synaptic transmission in the corticostriatal pathway

Neuropharmacology

Volumn 40, Issue 1, 2001, Pages 106-113

  Doreulee, Nanuli ^a   Yanovsky, Yevgenij ^a   Flagmeyer, Iris ^a   Stevens, David R ^a   Haas, Helmut L ^a   Brown, Ritchie E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Mouse; Presynaptic; Rat; Striatum

Indexed keywords

HISTAMINE H3 RECEPTOR; THIOPERAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; FACILITATION; HISTAMINE RELEASE; INTRACELLULAR RECORDING; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; STRIATE CORTEX; SYNAPTIC TRANSMISSION; VOLUNTARY MOVEMENT;

EID: 0033763416     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00101-5     Document Type: Article

References (31)

1. Direct evidence for increased continuous histamine release in the striatum of conscious freely moving rats produced by middle cerebral artery occlusion
2. Changes in the metabolism of histamine and monoamines after occlusion of the middle cerebral artery in rats
3. The functional anatomy of disorders of the basal ganglia
4. 3) of histamine receptor
5. 3 receptor-mediated depression of synaptic transmission in the dentate gyrus of the rat in vitro
6. Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses
7. Endogeneous adenosine mediates the presynaptic inhibition induced by agylcemia at corticostriatal synapses
8. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression
9. Involvement of GABA systems in feedback regulation of glutamate- and GABA-mediated synaptic potentials in rat neostriatum
10. The corticostriatal projection: From synaptic plasticity to dysfunctions of the basal ganglia
11. 3 antagonist binding sites in rat brain
12. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro
13. 1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro
14. 3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata
15. 3-receptor binding in the normal human basal ganglia: Comparison with Huntington's and Parkinson's disease cases
16. Electrophysiology of histamine receptors
17. Membrane properties and synaptic responses of rat striatal neurones in vitro
18. 3 receptor agonists and antagonists
19. 3 receptor
20. Presynaptic actions of carbachol and adenosine on corticostriatal synaptic transmission studied in vitro
21. 3) visualized in the brain of human and non-human primates
22. 2 receptors in Huntington's chorea but not in Parkinson's disease: Comparison with animal models
23. 2 receptors in neurones dissociated from rat neostriatum
24. Histamine-immunoreactive nerve fibres in the rat brain
25. 3 receptors in rat brain areas
26. Ontogenetic development of histamine receptor subtypes in rat brain demonstrated by quantitative autoradiography
27. 3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: An autoradiographic study
28. 3 receptors
29. Histaminergic transmission in the mammalian brain
30. 125I]iodoaminopotentidine
31. Short-term synaptic plasticity